FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/19/2026
Back to search
Official data from USPTO
HUGEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5
Filing date
04/09/2024
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
MASON, JARED MICHAEL
Law office
N10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "HUGEL" in black and to the left of which are three stylized curves forming a circle with the lower curve in blue and the other two in light blue; the white areas are intended to show background or transparent areas and are not claimed as a feature of the mark.
Holders and representatives
Holders
HUGEL INC.
Representatives
James R Menker Holley & Menker, PA
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical reagents for pharmaceutical purposes; chemical preparations for pharmaceutical purposes for the treatment of neurological disordersmuscle dystoniasmooth muscle disordersautonomic nerve disordersheadacheswrinkleshyperhidrosis and cerebral palsy; chemical preparations for pharmaceutical purposes for the treatment of sports injuriesinjured or torn skinmuscleligaments or bone; chemical preparations for pharmaceutical purposes for the treatment of tremorsspasmodic smoothstriated or cardiac muscles; chemical preparations for pharmaceutical purposes for the treatment of painsmooth muscle painstriated muscle paincardiac muscle painneuropathic paininflammatory painvisceral painchronic painacute paintraumatic injury painreferred paingrowing painhunger painintractable painlabor painorganic painphantom limb painpostprandial painpsychogenic painback painpost-stroke paincancer painnociceptive painheadache painprostatic painbladder pain; pharmaceutical agents for epidermis; antibiotic ointments for pharmaceutical purposes; anti-itch ointments for pharmaceutical purposes; dermatology ointments for pharmaceutical purposes; medicated ointments for treating dermatological conditions; preparations of microorganisms for medical or veterinary use; adjuvants for medical purposes; appetite suppressants for medical purposes; drugs for medical purposespain relief medications; drugs for medical purposes for the treatment of neurological disordersmuscle dystoniasmooth muscle disordersautonomic nerve disordersheadacheswrinkleshyperhidrosis and cerebral palsy; drugs for medical purposes for the treatment of sports injuriesinjured or torn skinmuscleligaments or bone; drugs for medical purposes for the treatment of tremorsspasmodic smoothstriated or cardiac muscles; drugs for medical purposes for the treatment of painsmooth muscle painstriated muscle paincardiac muscle painneuropathic paininflammatory painvisceral painchronic painacute paintraumatic injury painreferred paingrowing painhunger painintractable painlabor painorganic painphantom limb painpostprandial painpsychogenic painback painpost-stroke paincancer painnociceptive painheadache painprostatic painbladder pain; dermatological pharmaceutical products; pharmaceutical preparations for skin care; medicated hair lotions; medicated lotions for skinhairsunburnfacebody and hands; medicated lotions for treating dermatological conditions; pharmaceutical skin lotions; medical oral care gels for activation of tissues; medical topical gels for activation of skin tissues; hyaluronic acid preparations for medical purposes; medicines for human purposes being antivirals; medicines for human purposes for treating dermatological conditions; medicines for human purposemedicines for skin care; medicines for human purposesmedicinal preparations for the mouth to be applied in the form of dropscapsulestablets and compressed tablets; medicines for human purposes for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for treating dystonia; pharmaceutical products for skin care for animals; pharmaceutical preparations used in cosmetic surgery; pharmaceutical preparations for use in treating urogenital system diseases and conditionsoveractive bladder and urinary incontinence; pharmaceutical preparations for digestive system; pharmacological preparations for skin care; pharmaceutical preparations for treating peripheral neurological diseases and disorders; pharmaceutical preparations for treating central neurological diseases and disorders; pharmaceutical preparations for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for the treatment of orthopedic disordership dislocationspinal column deformationcurvature of the spinescoliosislordosiskyphosis; pharmaceutical preparations for smooth muscle disordersautonomic nerve disordersheadacheshyperhidrosissports injuriescerebral palsytremors and pain; pharmaceutical preparations for the treatment of wrinkles; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations mainly based on hyaluronic acid for treatmentsinjectable for intradermal and subcutaneous application for facial and body skin tightening and smoothing; injectable dermal fillers; air deodorizing preparations; mothproof paper; pharmaceutical preparations being antivirals containing botulinum toxin; pharmaceutical preparations containing botulinum toxin for the treatment of wrinkles; pharmaceutical preparations containing botulinum toxin fragments for the treatment of wrinkles; surgical implants comprised of living tissues; bacterial toxins for medical purposesbotulinum toxin for medical use for use in the treatment of excessive sweating; botulinum toxin for the treatment of facial wrinkles; botulinum toxin for medical use for use in the treatment of excessive sweatingexcessive eye blinkingneuropathy painfacial wrinklesheadachepainspasmdystoniaurogenital system diseases and conditionsskin disorders; bacterial poisons; food for babies; biological preparations for the treatment of cancer; biological preparations for medical purposes for the treatment of aesthetic dermatologyorthopedicsarthritis and ophthalmology; biological preparations for medical purposes for the treatment of neurological disordersmuscle dystoniasmooth muscle disordersautonomic nerve disordersheadacheswrinkleshyperhidrosis and cerebral palsy; biological preparations for medical purposes for the treatment of tremorsspasmodic smoothstriated or cardiac muscles; biological preparations for veterinary purposes for the treatment of aesthetic dermatologyorthopedicsarthritis and ophthalmology; bacterial preparations for medical purposes; bacterial preparations for veterinary use; chemical reagents for medical or veterinary purposes; pre-filled syringes for medical purposes filled with pain relief medication; pre-filled syringes for medical purposes containing saline for rehydrating the skinpharmaceuticals for dissolving skin wrinkles; pre-filled self injection syringes for medical purposes for injection of prefilled hyaluronic acid; medicinal creams for skin care; medicated cleansers for skin and wounds; medicated moisturizing creams; nutritional supplements; protein dietary supplements; disposable baby diapers; disposable diapers for pets; composite materials for dental and dental technical purposes; skin grafts; medicated skin care preparations; implants comprising living tissue for use in guided tissue regeneration; pharmaceuticals in the nature of sports cream for relief of painanalgesicsanti-inflammatoriescough syrupspain relief medicationfungal medicationsantisepticscold sore treatment preparationsallergy medicationsdecongestantsvitamin and mineral supplementsacne medicationsmuscle relaxantsanti-itch creammedicated candiesmedicated bath preparationsmedicated beauty soapmedicated confectioneryeye dropsdermatologicals; gastrodia elata for pharmaceutical purposes; medical X-ray contrast agents; oxygen for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants for hygiene purposes; contact lens cleaning preparations; chewing gum for medical purposes; biological herbicides; bandages for dressings
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/03/2026
FIMP
FINAL DISPOSITION PROCESSED
03/03/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/12/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/27/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/27/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/19/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2025
PUBO
PUBLISHED FOR OPPOSITION
06/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/28/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/08/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/21/2025
RFNT
REFUSAL PROCESSED BY IB
11/17/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/29/2024
RFRR
REFUSAL PROCESSED BY MPU
10/29/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/24/2024
CNRT
NON-FINAL ACTION WRITTEN
10/23/2024
DOCK
ASSIGNED TO EXAMINER
10/22/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/06/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/29/2024
Continuous trademark protection
Get notified about every new filing that threatens HUGEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.